A wearable device that alerts people with food allergies before a reaction begins has the potential to reduce life-threatening anaphylaxis and transform allergy management from reactive to preventive care.
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some of the most treatment-resistant tumors into forms that are more manageable with existing drugs.
Lasers cut precisely and without contact—ideal for surgery. The problem is that in hard tissues such as bone, they are too slow and do not cut deep enough. Researchers at the University of Basel have now demonstrated a way to cut much deeper and faster with a surgical laser than with previous laser systems.
Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, hemophilia and, recently, Huntington’s disease, a fatal neurological disorder.
An AI can accurately diagnose a rare endocrinological condition just by analyzing pictures of the back of the hand and the clenched fist. The privacy-conscious achievement by Kobe University holds promise for establishing more efficient referral systems and reducing health care disparities across communities.
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack.
A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida.
Learn how a new laser-based therapy is giving patients with aggressive brain cancer a stronger chance at survival.
Learn more about Pico-C, a tool that helps reveal the genome’s structure during the first days of life.
ZURICH, Feb. 25, 2026 /PRNewswire/ — Polaroid Therapeutics (PTx) today announces that POLTX_Fiber™ has received the CE Mark as a Class IIb medical device with APT™ (Antimicrobial Polymer Technology).